Gulf International Bank UK Ltd Sells 14,794 Shares of Danaher Corporation (NYSE:DHR)

Key Points

• Gulf International Bank UK Ltd reduced its stake in Danaher Corporation by 28.1%, selling 14,794 shares and holding a total of 37,877 shares valued at approximately $7.76 million as of the end of the most recent quarter.
• Analysts have issued mixed ratings on Danaher, with price targets ranging from $225 to $247.61, and the company holds an average analyst rating of "Moderate Buy".
• Danaher reported earnings of $1.80 EPS and revenues of $5.94 billion, exceeding analyst estimates, with a year-over-year revenue increase of 3.4%.

Gulf International Bank UK Ltd cut its stake in Danaher Corporation (NYSE:DHR - Free Report) by 28.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,877 shares of the conglomerate's stock after selling 14,794 shares during the period. Gulf International Bank UK Ltd's holdings in Danaher were worth $7,764,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new stake in Danaher in the fourth quarter valued at approximately $27,000. GHP Investment Advisors Inc. boosted its holdings in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC boosted its holdings in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher during the 1st quarter worth approximately $31,000. Finally, Dunhill Financial LLC boosted its holdings in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on DHR. Deutsche Bank Aktiengesellschaft cut their price target on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. UBS Group cut their price target on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Robert W. Baird increased their price target on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Jefferies Financial Group cut their price target on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Finally, Argus cut their target price on Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Three equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $247.61.

Danaher Trading Up 3.0%

NYSE DHR opened at $205.79 on Wednesday. The firm has a market capitalization of $147.36 billion, a P/E ratio of 43.79, a PEG ratio of 2.79 and a beta of 0.73. The business has a fifty day simple moving average of $198.95 and a 200 day simple moving average of $200.34. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. Danaher's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.72 EPS. On average, analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.